Toward a treaty on safety and cost-effectiveness of pharmaceuticals and medical devices: enhancing an endangered global public good

por Faunce, Thomas Alured
Publicado 2006

Challenges for Australia's Bio/Nanopharma Policies: trade deals, public goods and reference pricing in sustainable industrial renewal

por Faunce, Thomas A
Publicado 2007

'Linkage' pharmaceutical evergreening in Canada and Australia

por Faunce, Thomas A, Lexchin, Joel
Publicado 2007

Three Proposals for Rewarding Novel Health Technologies Benefiting People Living in Poverty. A Comparative Analysis of Prize Funds, Health Impact Funds and a Cost-Effectiveness/Com...

por Faunce, Thomas Alured, Nasu, Hitoshi
Publicado 2008

Balancing intellectual monopoly privileges and the need for essential medicines

por Martin, Greg, Sorenson, Corinna, Faunce, Thomas
Publicado 2007

Policy challenges from the "White" Senate inquiry into workplace-related health impacts of toxic dusts and nanoparticles

por Faunce, Thomas A, Walters, Haydn, Williams, Trevor, Bryant, David, Jennings, Martin, Musk, Bill
Publicado 2006

Assessing the impact of the Australia-United States Free Trade Agreement on Australian and global medicines policy

por Faunce, Thomas, Doran, Evan, Henry, David, Drahos, Peter, Searles, Andrew, Pekarsky, Brita, Neville, Warwick
Publicado 2005